AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021
Aug 3, 2021
32814_dirs_2021-08-03_d3357654-6944-4b51-ab02-771fef54cab8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2021-08-02
Reporting Person: Granowitz Craig B (SVP, Chief Medical Officer)
More from LEXICON PHARMACEUTICALS, INC.
Report Publication Announcement
2026
May 7
Capital/Financing Update
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3